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1. Introduction 
Renal replacement therapy (RRT) has become an established component of modern critical 
care. Approximately 60 - 70% of critically ill patients with severe acute kidney injury (AKI) 
are treated with RRT which represents ~5% of all intensive care unit (ICU) admissions 
(Ostermann & Chang, 2008; Uchino et al., 2005). Thirty years ago, intermittent 
haemodialysis for the critically ill patient with AKI was typically delivered three times 
weekly using dialysis machines without accurate volumetric control, acetate-based dialysate 
and unmodified cellulosic membrane dialysers. Peritoneal dialysis was performed with 
hard catheters and low dwell volumes. Since then, the types of RRT used in ICU and the 
available kits have advanced significantly. 
Despite its worldwide use, the practice of RRT is variable. The main reasons are differences 
in expertise of nursing and medical staff, local availability of machines and lack of robust 
clinical data to support one technique over another (Pannu et al., 2008). Several important 
aspects related to the management of RRT, including mode, optimal indications and timing 
are the focus of ongoing discussion and opposing views. 
2. Aims of RRT 
AKI in critically ill patients manifests itself with varying degrees of uraemia, fluid 
accumulation, acid base disturbance and non-renal dysfunction. The clinical course can be 
very variable. RRT for AKI is predominantly supportive with the aim to maintain metabolic 
and volume haemostasis and to prevent uraemic complications and dysfunction of other 
organs during the critical illness until renal function recovers. It is important that these 
benefits of RRT are balanced by potential harm, including risks related to central venous 
access, infections and anticoagulation (Oudemans-van Straaten, 2007). 
3. Practice of RRT 
3.1 Indications for RRT 
In the setting of chronic kidney disease, the European Best Practice Guidelines 
recommend starting chronic dialysis when a patient with an estimated glomerular 
filtration rate (GFR) of <15ml/min/1.73m2 has symptoms or signs of uraemia, fluid 
overload or malnutrition in spite of medical therapy or before estimated GFR has fallen to 
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<6ml/min/1.73m2 in an asymptomatic patient (European Best Practice Guidelines, 2005). 
The overall aim is to replace renal function. The situation is very different in the acute 
setting where RRT for AKI is predominantly viewed as organ support until kidney 
function recovers. Although acute RRT should be started before the onset of any 
potentially life threatening complications of uraemia, the optimal time and indications 
remain controversial. Potential benefits of early initiation are more rapid 
metabolic/uraemic control and more effective prevention and management of fluid 
overload (Gibney et al., 2008).  Some data also suggest that RRT before the onset of severe 
AKI may attenuate kidney-specific and non-kidney organ injury from acidemia, uremia, 
fluid overload, and systemic inflammation, and potentially translate into improved 
survival and earlier recovery of kidney function (Clark et al., 2006; Matson et al., 2004). 
The obvious counterargument is that early RRT might subject patients who would recover 
renal function with conservative treatment alone, to the potential risks associated with 
RRT (Vinsonneau & Monchi, 2011). Delay of RRT until AKI is severe avoids treatment in 
patients with potentially recoverable AKI but increases the risk of uraemic complications 
and fluid overload. 
3.1.1 Indicators for initiation of RRT 
Studies exploring the optimal indication for starting RRT have used different parameters, 
including arbitrary cut-offs for serum creatinine, serum urea or urine output, fluid balance, 
time from ICU admission or time after onset of AKI. Several retrospective studies have 
shown an association between lower serum urea levels at time of RRT and better outcomes 
(Gettings et al., 1999; Liu et al., 2006; Shiao et al., 2009). Liu et al reported a lower mortality 
in 122 patients in a mixed ICU who had serum urea levels ≤27 mmol/L (≤76 mg/dL) on the 
day when RRT was started compared to 121 patients with higher urea values (Liu et al., 
2006). When adjusted for age, hepatic failure, sepsis, thrombocytopenia and serum 
creatinine, the relative risk of death with a higher urea level at time of RRT was 1.85 (95% CI 
1.16 – 2.96). Improved mortality was also reported in other retrospective studies when RRT 
was instituted with serum urea <21 mmol/L (Gettings et al., 1999)  or <23 mmol/L (Shiao et 
al., 2009) compared to higher levels. The authors made the conclusion that  “early RRT may 
be better than late RRT”. However, 2 larger studies did not find any correlation between 
serum urea at time of RRT and outcome (Bagshaw et al., 2009; Ostermann & Chang, 2009). 
Instead, they showed that patients who had a serum creatinine < 309 μmol/L at time of RRT 
had a greater risk of dying compared to those with higher serum creatinine levels. Other 
studies found a better outcome in patients with a shorter time from ICU admission (Payen et 
al., 2008; Piccinni et al., 2006), a higher urine output at time of RRT (Sughara & Suzuki, 
2004), and a shorter time between onset of AKI and RRT (Ostermann & Chang, 2009). 
Despite the perception that early RRT may be better, the data are conflicting (Bagshaw et al., 
2009; Bouman et al., 2002; Demirkilic et al., 2004; Elahi et al., 2004; Gettings et al., 1999; Liu et 
al, 2006; Ostermann & Chang, 2009; Payen et al., 2008; Piccinni et al., 2006; Shiao et al., 2009; 
Sughara et al., 2004). There are only 2 randomized controlled trials (RCTs) exploring the 
impact of timing of RRT (Bouman et al., 2002; Sughara & Suzuki, 2004). The majority of data 
stem from retrospective analyses with different biochemical cut-offs to distinguish between 
early and late treatment. Therefore, it cannot be excluded that patients in the “early” RRT 
group simply had less severe AKI and that patients in the “late” group received RRT too 
late, ie. after the onset of uraemic complications. Finally, the interpretation of non-
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randomized studies is limited by the exclusion of patients who met criteria for early RRT 
but never received it. 
In the largest prospective RCT investigating the role of timing, 106 predominantly cardiac 
surgical patients with AKI were randomized to three groups: early high-volume 
continuous venovenous haemofiltration (CVVHF) (n=35), early low-volume CVVHF 
(n=35) and late low-volume CVVHF (n=36) (Bouman et al., 2002). There were no 
significant differences in 28 day mortality or duration of AKI between the groups. All 
hospital survivors recovered renal function except for one patient in the early low volume 
CVVH group. Of interest, 4 patients in the late arm recovered renal function 
spontaneously and 2 patients died before the criteria for CVVH were met. The authors 
came to the conclusion that there was no significant benefit with either early CVVH or 
high filtration rates for patients with oliguric AKI. A large retrospective analysis of 1,847 
ICU patients treated with RRT for AKI demonstrated that the most important 
independent risk factors for ICU mortality were mechanical ventilation, associated organ 
failure, pre-existing chronic health problems, acidosis, oliguria and age (Ostermann & 
Chang, 2009). There was no association between serum urea and creatinine at time of RRT 
and outcome. The paper concluded that the decision to start RRT should depend less on 
classic renal parameters but more on the clinical status of the patient, degree of acidosis, 
risk of fluid overload and associated organ failure. 
The negative impact of fluid overload is increasingly being recognised (Bouchard et al., 
2009; Payen et al., 2008). In a retrospective analysis of 398 ICU patients, Bouchard et al 
found a significantly higher ICU mortality in patients who had gained 1-20% or more in 
body weight between ICU admission and day of RRT compared to patients without any 
weight gain (Bouchard et al., 2009). Oliguria and fluid overload in the context of AKI 
should be viewed as triggers for RRT independent of actual serum urea and creatinine 
results. 
In summary, based on the existing data in the literature, the decision when to start RRT 
should take into account the patient’s severity of illness and its trends, degree of fluid 
overload and number and types of associated organ failure. Individual serum creatinine 
or urea parameters are not adequate in identifying the optimal time for RRT. Obviously, 
in patients with a futile prognosis RRT may not be appropriate. In this case, withholding 
RRT constitutes good end-of life care (Gabbay & Meyer, 2009).  
3.2 Choice of RRT modality 
Current RRT options for ICU patients with AKI are continuous modes [continuous 
haemofiltration (CVVHF), continuous haemodialysis (CVVHD) and continuous 
haemodiafiltration (CVVHDF)], intermittent haemodialysis (HD), hybrid techniques like 
slow extended haemodialysis (SLED) or prolonged intermittent renal replacement therapy 
(PIRRT) and acute peritoneal dialysis.  Some characteristics of the different modalities are 
listed in Table 1.  
Continuous RRT is often perceived to offer greater cardiovascular stability compared to 
traditional intermittent HD. However, intermittent techniques have evolved over the last 20 
years. HD machines now have accurate fluid balance control modules with real-time 
indirect assessment of relative changes in blood volume which allow rapid fluid removal 
with less haemodynamic instability. A switch towards bicarbonate-based dialysate and less 
bioincompatible membranes, together with a recognition of the importance of higher 
dialysate sodium concentrations and cooled dialysate have also led to a reduced the risk of 
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intradialytic hypotension. Advantages of intermittent HD are the reduced need for 
anticoagulation, lower financial costs and greater flexibility which ultimately allows more 
time for investigations and therapies, including active rehabilitation. Small solutes such as 
potassium are removed more efficiently with HD which may be particularly beneficial in the 
setting of acute life threatening hyperkalaemia. 
 
 
CVVH CVVHD CVVHDF 
Intermittent 
HD 
SLED / 
PIRRT 
PD 
Solute transport Convection Diffusion Convection
+ diffusion
Diffusion Diffusion Diffusion 
Therapy 
time/day 
24 hours 24 hours variable 4 – 6 hours 6 – 12 
hours 
24 hours 
Blood flow  
(ml/min) 
100 - 250 100 - 250 100 - 250 200 - 350 100 - 300 none 
Urea clearance  
(ml/min) 
20- 40 25 – 45 25 – 45 150 – 180 90 – 140 15 - 35 
Need for  
Anticoagulation
Yes Yes Yes Not 
absolutely 
Not 
absolutely 
No 
Table 1. Comparison between different modes of RRT (adapted from Mehta et al., 1993) 
In addition to potentially better haemodynamic stability, continuous RRT offers the 
advantage of more sustained fluid removal and less fluctuations in fluid status and 
metabolic control. Obvious disadvantages are the need for continuous anticoagulation and 
less flexibility, including less time for the patient to participate in active rehabilitation. The 
rate of solute removal is lower than with intermittent HD. Over the last few years, there has 
been much debate whether haemofiltration offers additional benefits for patients with AKI 
and severe sepsis / septic shock beyond solute clearance (Peng Z et al., 2010). Proponents 
argue that RRT in the context of severe sepsis contributes to removal of soluble 
inflammatory mediators of sepsis and restores immune function through improved antigen-
presenting capability and leukocyte responsiveness (Honoré et al., 2007). Although this 
concept of “blood purification” is conceptually appealing, the evidence is limited to data 
from animal models and small human studies (Bouman et al., 2007).  
Although there are differences in capillary fibre structure and design, most ICUs use the 
same dialysers for CRRT, PIRRT and IHD. The resurgence of batch dialysis systems (for 
instance, Genius® , NxStage®) and the use of individual water purification systems 
(microfilters, water softeners, multiple pass reverse osmosis) coupled with endotoxin filters 
has made it possible to provide haemodialysis even without access to ultrapure water 
supply as in chronic haemodialysis units.   
3.2.1 Continuous versus intermittent RRT 
It is widely perceived that continuous modes may be better for critically ill patients with 
AKI. However, prospective randomised clinical trials have failed to confirm this. Based on 4 
different systematic reviews, there is no convincing evidence that continuous RRT is 
superior to intermittent HD in terms of mortality or renal recovery (Bagshaw et al., 2008; 
Kellum et al., 2002; Rabindranath et al., 2007; Tonelli et al., 2002). Although these analyses 
included different studies of varying methodological quality and size, the authors came to 
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similar conclusions. The Hemodiafe Study, a multicenter RCT comparing intermittent HD 
versus CVVHDF in patients with AKI and multiple-organ dysfunction syndrome (MODS), 
showed that it is possible to treat almost all critically ill patients with AKI with intermittent 
HD, provided strict guidelines to improve tolerance and metabolic control are adhered to 
(Vinsonneau et al., 2006). In the intermittent HD group, haemodynamic stability was 
maintained by using a high dialysate sodium concentration and dialysate cooled to 350C. 
There was no difference in outcome between both groups. 
Despite the lack of data that continuous RRT is superior to intermittent HD with regards to 
mortality or renal recovery, there is some evidence that fluid overload may be easier to 
control with continuous RRT compared to intermittent modalities. Retrospective analysis of 
data collected as part of the Program to improve Care in Acute Renal Disease (PICARD) 
study showed that patients treated with intermittent RRT continued to gain fluid in the 
subsequent days in contrast to patients on continuous RRT in whom the fluid balance was 
significantly better controlled (Bouchard et al., 2009). This observation makes intermittent 
HD less suitable for patients with major fluid overload and supports the recommendation to 
use continuous RRT for this patient group (Vanholder et al., 2011). 
Comparative studies of continuous and hybrid techniques are limited (Abe et al., 2010; 
Kielstein et al., 2004; Kumar et al., 2000; Kumar et al., 2004; Marshall et al., 2004). In a small 
trial, 39 patients were randomised to either CVVHF or 12-hour SLED (Kielstein et al., 2004). 
Cardiovascular tolerability and urea clearances were equivalent. However, less heparin was 
needed and acidosis was corrected faster in patients treated with SLED. In another 
randomised trial in 60 patients, CVVHDF was compared to 6 – 8 hours of SLED (Abe et al., 
2010). There was no difference in ICU or 30 day mortality but survivors in the SLED group 
had higher renal recovery rates and a shorter length of stay in ICU.  
3.2.2 Peritoneal dialysis versus continuous RRT 
Acute peritoneal dialysis in the ICU is possible but requires the insertion of a peritoneal 
dialysis catheter and relies on an intact peritoneum and adequate bowel movement. It is 
contraindicated in patients with abdominal pathology. Solute clearance and fluid removal 
are generally less predictable and controllable and may be reduced in patients with 
impaired mesenteric blood flow. Removal of large volumes of fluid may not be possible 
with small dwell volumes, especially in the first 2 weeks after insertion of the peritoneal 
catheter. 
There are only limited data comparing peritoneal dialysis to continuous RRT in adults 
(Gangji et al., 2005; Swartz et al., 2005). In a Vietnamese study in patients with infection 
associated AKI, CVVHF was superior but the applied peritoneal dialysis strategies were  
different from current practice (Phu et al., 2002).  Another study showed not difference but 
the clearance delivered by peritoneal dialysis was low (Gabriel et al., 2008). 
In summary, analysis of the currently published studies shows no clear advantage of one 
modality over the other in terms of mortality or renal recovery. The decision regarding type 
of RRT should take into account the individual patient’s clinical condition, medical and 
nursing expertise, and the availability of RRT machines. Regular education and training of 
those who provide RRT is essential with emphasis on the characteristics and values of each 
RRT technique. During the dynamic course of critical illness the type of RRT modality may 
have to change in response to the varying needs of the patient. Most clinicians choose 
continuous RRT for patients with cardiovascular compromise, significant fluid overload and 
multi-organ failure, and an intermittent mode for cardiovascularly stable patients 
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(Kanagasundaram, 2007; VA NIH Acute Renal Failure Trial Network et al., 2008)  Although 
the risk of hypotension is increased during intermittent HD, the Hemodiafe study showed 
that the introduction of a relatively simple treatment algorithm including use of a high 
dialysate sodium concentration of 145 mmol/L in combination with cooled dialysate and 
stopping vasodilator infusions, markedly reduced the risk of intradialytic hypotension 
(Vinsonneau et al., 2006). Hybrid techniques like SLED / PIRRT offer the advantages of both 
CRRT and intermittent HD, including haemodynamic stability, increased patient mobility 
and reduced financial costs. 
3.3 General care 
Severe AKI results in hypercatabolism and altered drug metabolism. Provision of adequate 
nutrition and attention to drug dosing are essential when looking after patients on RRT. 
While no particular mode or filter is recommended, it is important to understand the 
characteristics of these different RRT techniques and potential differences in drug removal. 
Both, under-treatment and drug toxicity have been reported in patients on RRT.  
4. Conclusions 
RRT is a form of organ support for critically ill patients with AKI. The most commonly used 
modalities are continuous haemo(dia)filtration and intermittent modes. There is no evidence 
that one mode is superior to another in terms of mortality or renal recovery. Except for a few 
specific indications, each modality can be considered a valid RRT option for critically ill 
patients with AKI. The choice should depend on the patient’s clinical condition, medical and 
nursing expertise and local availability of machines. Intermittent HD is an acceptable option 
for critically ill patients with AKI, including patients with MODS provided clear guidelines 
are adhered to in order to prevent haemodynamic instability. For patients with significant 
fluid overload, continuous RRT appears more appropriate. 
It is widely acknowledged that the way RRT is delivered has an impact on quality and 
outcome of patients with severe AKI. The value of regular education and training of those 
who deliver RRT, and attention to concurrent interventions (drug dosing, nutrition, fluid 
management) cannot be emphasized enough. There is a clear role for each different 
modality in the management of AKI in ICU. RRT should be individualised depending on 
the patient’s varying needs during the critical illness. 
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